TY  - GEN
AU  - Sanchez-Garcia,Joaquin
AU  - Falantes,Jose
AU  - Medina Perez,Angeles
AU  - Hernandez-Mohedo,Francisca
AU  - Hermosin,Lourdes
AU  - Torres-Sabariego,Angeles
AU  - Bailen,Alicia
AU  - Hernandez-Sanchez,Jesus M
AU  - Solé Rodriguez,María
AU  - Casaño,Francisco Javier
AU  - Calderon,Cristina
AU  - Labrador,Maria
AU  - Vahí,Maria
AU  - Serrano,Josefina
AU  - Lumbreras,Eva
AU  - Hernández-Rivas,Jesus Maria
TI  - Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia
SN  - 1029-2403
PY  - 2019///0111
KW  - Aged
KW  - Aged, 80 and over
KW  - Anemia
KW  - epidemiology
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Azacitidine
KW  - Blood Transfusion
KW  - methods
KW  - Chromosome Deletion
KW  - Chromosomes, Human, Pair 5
KW  - genetics
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Palliative Care
KW  - Prognosis
KW  - Prospective Studies
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/10428194.2017.1366998
ER  -